Ask an Expert: Why Are There So Many COVID-19 Vaccines — and Is It Better to Have More? Dec 17 4 min read verified COVID-19COVAXCross-postsVaccine development
How small clinical trial sample sizes can offer important findings Dec 1 3 min read verified COVID-19EbolaExplainerVaccine development
10 things you should know about vaccine candidates Nov 27 9 min read verified COVID-19COVAXCross-postsVaccine development
Equal, rapid access to COVID-19 vaccines won’t just save lives; it will save money Nov 26 3 min read verified COVID-19Vaccine development
Moderna follows Pfizer with exciting vaccine news – how to read these dramatic developments Nov 18 6 min read verified COVID-19Cross-postsVaccine development
How deliberately infecting volunteers with COVID-19 could help accelerate vaccine development Nov 5 4 min read verified COVID-19COVAXVaccine development
Why we need a “portfolio approach” to COVID-19 vaccine development Oct 20 5 min read verified COVID-19Cross-postsVaccine development
How emergency use authorisations could accelerate access to COVID-19 vaccines Oct 7 6 min read verified COVID-19Vaccine developmentVaccine manufacturing
How do vaccine challenge trials ensure the benefits outweigh the risks? Sep 30 5 min read verified COVID-19COVAXVaccine development
COVID-19 vaccines: what happens after clinical trials Sep 14 7 min read verified COVID-19COVAXVaccine developmentExplained